Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Myositis? 150 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 150 reports of Myositis have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.1% of all adverse event reports for CYCLOPHOSPHAMIDE.

150
Reports of Myositis with CYCLOPHOSPHAMIDE
0.1%
of all CYCLOPHOSPHAMIDE reports
49
Deaths
90
Hospitalizations

How Dangerous Is Myositis From CYCLOPHOSPHAMIDE?

Of the 150 reports, 49 (32.7%) resulted in death, 90 (60.0%) required hospitalization, and 54 (36.0%) were considered life-threatening.

Is Myositis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMIDE. However, 150 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Myositis?

NIVOLUMAB (682) PEMBROLIZUMAB (596) ATORVASTATIN (448) METHOTREXATE (418) PREDNISONE (369) RITUXIMAB (355) ADALIMUMAB (344) IPILIMUMAB (305) ATEZOLIZUMAB (249) INFLIXIMAB (249)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Myositis Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Myositis Reports All Drugs Causing Myositis CYCLOPHOSPHAMIDE Demographics